Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Chembio Diagnostics, Inc. (CEMI) since 2014 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Chembio Diagnostics, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1092662.
Total stock buying since 2014: $1,231,641.
Total stock sales since 2014: $544,045.
Total stock option exercises since 2014: $720,633.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2023 | 1,490,120 | $663,465 | 0 | $0 | 394,315 | $0 |
| 2022 | 0 | $0 | 0 | $0 | 141,894 | $0 |
| 2021 | 0 | $0 | 0 | $0 | 115,383 | $0 |
| 2019 | 10,000 | $44,400 | 30,000 | $214,435 | 46,875 | $163,125 |
| 2018 | 49,815 | $317,351 | 0 | $0 | 121,640 | $263,625 |
| 2017 | 6,250 | $35,981 | 0 | $0 | 27,417 | $108,719 |
| 2016 | 30,000 | $162,690 | 28,000 | $239,590 | 52,948 | $185,164 |
| 2015 | 0 | $0 | 20,000 | $90,020 | 0 | $0 |
| 2014 | 1,800 | $7,754 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2023-04 | 1,490,120 | $663,465 | 0 | $0 | 0 | $0 |
| 2023-03 | 0 | $0 | 0 | $0 | 340,744 | $0 |
| 2023-01 | 0 | $0 | 0 | $0 | 53,571 | $0 |
| 2022-12 | 0 | $0 | 0 | $0 | 4,893 | $0 |
| 2022-10 | 0 | $0 | 0 | $0 | 10,594 | $0 |
| 2022-06 | 0 | $0 | 0 | $0 | 4,101 | $0 |
| 2022-03 | 0 | $0 | 0 | $0 | 122,306 | $0 |
| 2021-12 | 0 | $0 | 0 | $0 | 4,892 | $0 |
| 2021-06 | 0 | $0 | 0 | $0 | 32,628 | $0 |
| 2021-03 | 0 | $0 | 0 | $0 | 77,863 | $0 |
| 2019-11 | 10,000 | $44,400 | 0 | $0 | 0 | $0 |
| 2019-05 | 0 | $0 | 30,000 | $214,435 | 46,875 | $163,125 |
| 2018-11 | 35,000 | $217,350 | 0 | $0 | 0 | $0 |
| 2018-06 | 0 | $0 | 0 | $0 | 20,000 | $112,800 |
| 2018-05 | 0 | $0 | 0 | $0 | 5,000 | $22,500 |
| 2018-02 | 14,815 | $100,001 | 0 | $0 | 36,875 | $128,325 |
| 2018-01 | 0 | $0 | 0 | $0 | 59,765 | $0 |
| 2017-08 | 0 | $0 | 0 | $0 | 9,448 | $42,043 |
| 2017-07 | 0 | $0 | 0 | $0 | 10,000 | $34,800 |
| 2017-06 | 6,250 | $35,981 | 0 | $0 | 0 | $0 |
| 2017-02 | 0 | $0 | 0 | $0 | 7,969 | $31,876 |
| 2016-10 | 3,000 | $21,480 | 0 | $0 | 0 | $0 |
| 2016-09 | 0 | $0 | 0 | $0 | 28,605 | $80,094 |
| 2016-08 | 27,000 | $141,210 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2023-04-25 | Edelman Joseph (10% Owner) | Buy | 133,742 | .45 | 60,183 |
| 2023-04-24 | Edelman Joseph (10% Owner) | Buy | 39,506 | .45 | 17,777 |
| 2023-04-21 | Edelman Joseph (10% Owner) | Buy | 70,200 | .45 | 31,449 |
| 2023-04-20 | Edelman Joseph (10% Owner) | Buy | 56,000 | .45 | 25,200 |
| 2023-04-19 | Edelman Joseph (10% Owner) | Buy | 137,000 | .45 | 61,376 |
| 2023-04-18 | Edelman Joseph (10% Owner) | Buy | 15,800 | .45 | 7,078 |
| 2023-04-17 | Edelman Joseph (10% Owner) | Buy | 4,800 | .45 | 2,160 |
| 2023-04-14 | Edelman Joseph (10% Owner) | Buy | 11,500 | .45 | 5,175 |
| 2023-04-13 | Edelman Joseph (10% Owner) | Buy | 140,134 | .45 | 63,060 |
| 2023-04-11 | Edelman Joseph (10% Owner) | Buy | 129,000 | .44 | 56,760 |
| 2023-04-06 | Edelman Joseph (10% Owner) | Buy | 339,000 | .44 | 149,160 |
| 2023-04-05 | Edelman Joseph (10% Owner) | Buy | 217,500 | .45 | 97,875 |
| 2023-04-04 | Edelman Joseph (10% Owner) | Buy | 195,938 | .44 | 86,212 |
| 2023-03-16 | Eberly Richard (See Remarks) | Option Ex | 77,863 | .00 | 0 |
| 2023-03-15 | Angelico Paul (See remarks) | Option Ex | 7,885 | .00 | 0 |
| 2023-03-15 | Caso Charles (See Remarks) | Option Ex | 7,885 | .00 | 0 |
| 2023-03-15 | Bespalko David William | Option Ex | 5,735 | .00 | 0 |
| 2023-03-15 | Eberly Richard (See Remarks) | Option Ex | 38,710 | .00 | 0 |
| 2023-03-11 | Angelico Paul (See remarks) | Option Ex | 29,333 | .00 | 0 |
| 2023-03-11 | Caso Charles (See Remarks) | Option Ex | 29,333 | .00 | 0 |
| 2023-03-11 | Eberly Richard (See Remarks) | Option Ex | 144,000 | .00 | 0 |
| 2023-01-05 | Steenvoorden Lawrence J. (See remarks) | Option Ex | 53,571 | .00 | 0 |
| 2022-12-17 | Acheson David | Option Ex | 4,893 | .00 | 0 |
| 2022-10-28 | Angelico Paul (See remarks) | Option Ex | 10,594 | .00 | 0 |
| 2022-06-01 | Caso Charles (See Remarks) | Option Ex | 4,101 | .00 | 0 |
| 2022-03-16 | Eberly Richard (See Remarks) | Option Ex | 77,863 | .00 | 0 |
| 2022-03-15 | Bespalko David William | Option Ex | 5,734 | .00 | 0 |
| 2022-03-15 | Eberly Richard (See Remarks) | Option Ex | 38,709 | .00 | 0 |
| 2021-12-17 | Acheson David | Option Ex | 4,892 | .00 | 0 |
| 2021-06-24 | Potthoff John Gary | Option Ex | 16,314 | .00 | 0 |
| 2021-06-24 | Davis Katherine Lyon | Option Ex | 16,314 | .00 | 0 |
| 2021-03-16 | Eberly Richard (See Remarks) | Option Ex | 77,863 | .00 | 0 |
| 2019-11-11 | Potthoff John Gary | Buy | 10,000 | 4.44 | 44,400 |
| 2019-05-24 | Esfandiari Javan (See Remarks) | Sale | 9,744 | 6.95 | 67,730 |
| 2019-05-23 | Esfandiari Javan (See Remarks) | Sale | 12,956 | 7.15 | 92,583 |
| 2019-05-22 | Esfandiari Javan (See Remarks) | Sale | 7,300 | 7.41 | 54,122 |
| 2019-05-06 | Davis Katherine Lyon | Option Ex | 46,875 | 3.48 | 163,125 |
| 2018-11-14 | Potthoff John Gary | Buy | 20,000 | 5.80 | 116,100 |
| 2018-11-05 | Passas Robert (See Remarks) | Buy | 15,000 | 6.75 | 101,250 |
| 2018-06-13 | Esfandiari Javan (Chief Science/Tech Officer) | Option Ex | 20,000 | 5.64 | 112,800 |
| 2018-05-16 | Klugewicz Sharon W (President, Americas) | Option Ex | 5,000 | 4.50 | 22,500 |
| 2018-02-26 | Meller Gary | Option Ex | 36,875 | 3.48 | 128,325 |
| 2018-02-13 | Goldman Neil A (EVP & Chief Financial Officer) | Buy | 14,815 | 6.75 | 100,001 |
| 2018-01-16 | Esfandiari Javan (Chief Science/Tech Officer) | Option Ex | 59,765 | .00 | 0 |
| 2017-08-28 | Klugewicz Sharon W (President, Americas) | Option Ex | 9,448 | 4.45 | 42,043 |
| 2017-07-13 | Meller Gary | Option Ex | 10,000 | 3.48 | 34,800 |
| 2017-06-28 | Pessin Brian L. | Buy | 6,250 | 5.76 | 35,981 |
| 2017-02-14 | Esfandiari Javan (Chief Science/Tech Officer) | Option Ex | 7,969 | 4.00 | 31,876 |
| 2016-10-11 | Pessin Brian L. | Buy | 3,000 | 7.16 | 21,480 |
| 2016-09-20 | Kissinger Peter | Option Ex | 28,605 | 2.80 | 80,094 |
| 2016-08-16 | Pessin Brian L. | Buy | 27,000 | 5.23 | 141,210 |
| 2016-06-24 | Kissinger Peter | Option Ex | 1,126 | 3.60 | 4,053 |
| 2016-06-15 | Klugewicz Sharon W (Chief Operating Officer) | Sale | 3,000 | 8.40 | 25,200 |
| 2016-06-01 | Esfandiari Javan (Chief Science/Tech Officer) | Sale | 12,000 | 8.56 | 102,720 |
| 2016-05-31 | Esfandiari Javan (Chief Science/Tech Officer) | Sale | 13,000 | 8.59 | 111,670 |
| 2016-05-02 | Larkin Richard J (CFO) | Option Ex | 23,217 | 4.35 | 101,017 |
| 2015-05-29 | Esfandiari Javan (Chief Science/Technology Offic) | Sale | 20,000 | 4.50 | 90,020 |
| 2014-11-19 | Kissinger Peter | Buy | 1,800 | 4.31 | 7,754 |
Insider trading activities including stock purchases, stock sales, and option exercises of CEMI listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Chembio Diagnostics, Inc. (symbol CEMI, CIK number 1092662) see the Securities and Exchange Commission (SEC) website.